Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Precigen Inc (PGEN)

Precigen Inc (PGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Precigen Receives Orphan Drug Exclusivity for PAPZIMEOS (zopapogene imadenovec-drba) in the United States PR Newswire - Wed May 27, 6:00AM CDT

GERMANTOWN, Md. , May 27, 2026 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a commercial-stage biopharmaceutical company specializing in the advancement of innovative precision medicines to improve...

PGEN : 4.22 (-0.47%)
Precigen to Participate in Fireside Chats with J.P. Morgan and at the Goldman Sachs 47th Annual Global Healthcare Conference PR Newswire - Tue May 26, 7:05AM CDT

GERMANTOWN, Md. , May 26, 2026 /PRNewswire/ -- Precigen, Inc.  (Nasdaq: PGEN), a commercial-stage biopharmaceutical company specializing in the advancement of innovative precision medicines...

PGEN : 4.22 (-0.47%)
MarketBeat.com
Precigen Q1 Earnings Call Highlights MarketBeat - Wed May 13, 11:12PM CDT

Precigen (NASDAQ:PGEN) reported a sharp increase in first-quarter 2026 revenue as the company’s first commercial product, PAPZIMEOS, continued its U.S. launch following FDA approval in August 2025.On...

PGEN : 4.22 (-0.47%)
Precigen Reports First Quarter 2026 Financial Results and Business Updates PR Newswire - Wed May 13, 3:05PM CDT

GERMANTOWN, Md. , May 13, 2026 /PRNewswire/ --  Precigen, Inc. (Nasdaq: PGEN), a commercial-stage biopharmaceutical company specializing in the advancement of innovative precision medicines...

PGEN : 4.22 (-0.47%)
Precigen's First Commercial Quarter Will Test Whether PAPZIMEOS Revenue Can Justify the Pivot Barchart - Tue May 12, 4:09PM CDT

Barchart Research What to Expect from PGEN Earnings PGEN Generated May 12, 2026 Current Price $4.08 EPS Estimate $$-0.03 Consensus Rating Moderate Buy Average Move 9.60% Precigen's First Commercial Quarter...

PGEN : 4.22 (-0.47%)
Precigen to Announce First Quarter 2026 Financial Results and Provide Business Updates on May 13 PR Newswire - Thu May 7, 3:05PM CDT

GERMANTOWN, Md. , May 7, 2026 /PRNewswire/ --  Precigen, Inc.  (Nasdaq: PGEN), a commercial-stage biopharmaceutical company specializing in the advancement of innovative precision medicines...

PGEN : 4.22 (-0.47%)
Precigen to Participate in a Fireside Chat with H.C. Wainwright on March 31 PR Newswire - Mon Mar 30, 7:30AM CDT

GERMANTOWN, Md. , March 30, 2026 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a commercial-stage biopharmaceutical company specializing in the advancement of innovative precision medicines...

PGEN : 4.22 (-0.47%)
Precigen Reports Full Year 2025 Financial Results and Business Updates PR Newswire - Wed Mar 25, 3:05PM CDT

GERMANTOWN, Md. , March 25, 2026 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a commercial-stage biopharmaceutical company specializing in the advancement of innovative precision medicines...

PGEN : 4.22 (-0.47%)
Precigen Faces Mounting Losses as Analysts Brace for Widening Deficit Barchart - Tue Mar 24, 4:06PM CDT

PGEN : 4.22 (-0.47%)
Precigen to Announce Full Year 2025 Financial Results and Provide Business Updates on March 25 PR Newswire - Wed Mar 11, 3:05PM CDT

GERMANTOWN, Md. , March 11, 2026 /PRNewswire/ --  Precigen, Inc.  (Nasdaq: PGEN), a commercial-stage biopharmaceutical company specializing in the advancement of innovative precision medicines...

PGEN : 4.22 (-0.47%)

Barchart Exclusives

How Traders Can Play Broadcom Stock’s Bull Run With Less Upfront Money Barchart - 7 minutes ago
Broadcom’s bull run has traders eyeing bull put spreads, a defined-risk options strategy that can generate upfront income with less capital required. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.